RSS

CD8+ Treg cells

A biotechnology company, TxCell, Inserm Transfert and Nantes University have signed a R&D collaboration agreement for the development of chimeric antigen receptor (CAR) engineered CD8+Treg cells (CAR-Tregs). more

3 May 2017 11:44 News